Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NICUSeq: A Prospective Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants

NCT03290469 is registered in ClinicalTrials.gov with Illumina, Inc. as lead sponsor.

NCT NCT03290469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03290469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NICUSeq: A Prospective Trial to Evaluate the Clinical Utility of Human Whole Genome Sequencing (WGS) Compared to Standard of Care in Acute Care Neonates and Infants
Lead sponsor
Illumina, Inc.
Phase
Not applicable
Overall status
Completed
Start date
September 14, 2017
Completion date
January 13, 2020
Enrollment
355 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

rare diseases